The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1975, 115: 8-14.
Copyright © 1975 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kook, A. I.
Right arrow Articles by Trainin, N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kook, A. I.
Right arrow Articles by Trainin, N.

The Control Exerted by Thymic Hormone (THF) on Cellular cAMP Levels and Immune Reactivity of Spleen Cells in the MLC Assay1

Abraham I. Kook2 and Nathan Trainin3

From the Department of Cell Biology, The Weizmann Institute of Science, Rehovot, Israel

Abstract

We have shown previously that THF induces immunocompetence in lymphoid cells through the control of cellular cAMP levels and DNA synthesis. By the use of a one-way MLC assay it was now shown that the exposure of spleen cells to THF is accompanied by an increase, in the proliferative response of the responding cells. These effects are mediated by regulation of cellular levels of cAMP during the course of the MLC response. Thus, substances which modify cellular levels of cAMP such as DBcAMP, theophylline, and imidazole change the reactivity of cells exposed to THF in the MLC assay. It was also found here that cellular cAMP levels are critical in controlling the reactivity of normal spleen cells in the absence of THF. It is suggested that THF increases the number of competent cells in the spleen cell population capable of responding to antigenic stimulation in the MLC assay.

Footnotes

1 This work was supported by a grant of the Talisman Foundation, New York and by the National Institutes of Health, Agreement NCI-G-72-3890.

2 Send all correspondence to Dr. A. I. Kook, Department of Cell Biology, The Weizmann Institute of Science, Rehovot, Israel.

3 Harold L. Korda Professor of Cancer Research. Established Investigator of the Chief Scientist's Bureau Ministry of Health, Israel.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1975 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1975 by The American Association of Immunologists, Inc. All rights reserved.